Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

U.S. FDA Clears Takeda Uloric For Gout Indication

Feb 18 2009

• By PharmAsia News

Related Content

U.S. FDA Offers Up Revised PDUFA Date In June For Takeda’s Alogliptin

Dec 30 2008

Takeda Readying To Launch PPI Kapidex Within A Month

Feb 06 2009

Takeda’s Febuxostat Gets U.S. FDA Advisory Committee Nod for Gout; Cardio Risk Remains A Concern

Nov 25 2008

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window